Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 123002
Published online Sep 15, 2026. doi: 10.4251/wjgo.123002
Published online Sep 15, 2026. doi: 10.4251/wjgo.123002
Table 4 Gastric cancer evidence and clinical implications
| Pathway/biomarker | Evidence in gastric cancer | Potential clinical implication |
| FDX1 | Linked to cuproptosis sensitivity, copper-lactylation signaling, and immune infiltration in gastric cancer-related studies[97,121,122,131,132] | Candidate marker for cuproptosis susceptibility and rational selection of copper-modulating strategies[97,121,122,131,132] |
| DLAT/LIAS/LIPT1/DLD (lipoylation-related genes) | Altered expression of lipoylation-related genes has been associated with gastric cancer metabolism and prognosis[47,49-50,122] | May help define tumors with mitochondrial metabolic dependence and potential vulnerability to cuproptosis induction[31,47,122] |
| SLC31A1/ATP7A/ATP7B (copper transporters) | Copper transporter dysregulation may affect intracellular copper accumulation, angiogenesis, and response to platinum-based therapy[16,52-56] | Potential targets to enhance copper-mediated cytotoxicity or overcome chemotherapy resistance[52-56] |
| AOC1 | AOC1 down-regulation suppresses AKT signaling, epithelial-mesenchymal transition, proliferation, invasion, and migration in gastric cancer cells[124] | Candidate therapeutic and prognostic biomarker linked to tumor growth and metastasis[124] |
| ITGB1 | High ITGB1 expression is associated with poor prognosis in diffuse gastric cancer and may reduce sensitivity to copper ionophores[125,126] | Potential stratification marker and actionable node for enhancing cuproptosis-based therapy[125,126] |
| SERPINE1 | Elevated SERPINE1 expression in gastric adenocarcinoma is associated with proliferation, migration, and immunosuppressive features[128-130] | Candidate prognostic and immune-related marker that may guide combination strategies[128-130] |
- Citation: Fang YP, Liu SN, Liu FP, Gong JW, Zhang YF, Lu JH, Liu JW, Wang Q, Chen X. Cuproptosis in gastric cancer: Mechanisms and therapeutic opportunities. World J Gastrointest Oncol 2026; 18(9): 123002
- URL: https://www.wjgnet.com/1948-5204/full/v18/i9/123002.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123002